BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ixiaro regulatory update

Intercell said in its 2Q11 earnings that it began a comprehensive investigation and root cause analysis of a May voluntary recall of a single batch of its Ixiaro Japanese encephalitis (JE) vaccine to prevent recurrence....

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >